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Abstract
 
After the productive rearrangement of immunoglobulin (Ig) heavy chain genes, precursor
(pre-)B lymphocytes undergo a limited number of cell divisions in response to interleukin
(IL)-7. Here, we present evidence that this phase of IL-7–dependent expansion is constrained
by an inhibitory signal initiated by antigen receptor assembly. A line of pre-B cells from nor-
 
mal murine bone marrow that expresses a 
 
m
 
 heavy chain with a D-proximal V
 
H
 
7183.2 region
 
divides continuously in IL-7. IL-7 responsiveness ceases upon differentiation to the 
 
m
 
1
 
, 
 
k
 
1
 
stage, despite continuing expression of the IL-7 receptor (IL-7R), suggesting that antigen re-
ceptor assembly inhibits IL-7 responsiveness. This is confirmed by introduction of a rearranged
 
l
 
 light chain gene, which inhibits proliferative signaling through the IL-7R. Inhibition is spe-
cific to the IL-7R, because it is overcome by replacement of the IL-7R cytoplasmic domain
with corresponding sequences from the closely related IL-2R
 
b
 
 chain. Alteration of a single ty-
rosine residue, Tyr410, in the IL-7R cytoplasmic domain to phenylalanine also prevents the
inhibition of proliferation after antigen receptor assembly. Thus, the loss of IL-7 responsiveness
after antigen receptor assembly may be mediated through the recruitment of an inhibitory
molecule to this residue. Our findings identify a novel mechanism that limits cytokine-depen-
dent proliferation during B lymphopoiesis. This mechanism may be essential for the proper
regulation of peripheral B lymphocyte numbers.
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Introduction
 
A potent stimulus for the proliferation of immature B lym-
phocytes is provided by IL-7 (1), a cytokine secreted by
stromal cells in the bone marrow. IL-7 triggers cell division
by engagement of a heterodimeric receptor (IL-7R) that
contains a ligand-specific 
 
a
 
 chain (2), and a common 
 
g
 
chain shared with the receptors for IL-2, IL-4, IL-9, IL-13,
and IL-15 (3–7). We have shown elsewhere that prolifera-
tive signaling through the IL-7R is critically dependent on
the integrity of a single tyrosine residue in the cytoplasmic
domain of the 
 
a
 
 chain (8). This tyrosine residue is essential
for the ligand-induced recruitment of the effector enzyme
phosphatidylinositol 3-kinase (PI 3-k), through the Src ho-
mology 2 (SH2) domains in its regulatory subunit, p85 (9).
In mice, the ability of immature B cells to divide in re-
sponse to IL-7 changes with their developmental progres-
sion. Progenitor (pro-)B cells, which have yet to complete
Ig heavy chain (
 
IgH
 
) gene rearrangement, require stromal
cell contact as well as IL-7 to divide (10, 11). Productive
 
IgH
 
 rearrangement triggers progression to the precursor
(pre-)B cell stage, at which IL-7 alone is sufficient to pro-
voke proliferation (1, 12, 13). Pre-B cells undergo only a
limited number of cell divisions before they differentiate
into IL-7–unresponsive, mature B lymphocytes, which ex-
press a functional antigen receptor (14, 15). It remains un-
clear how IL-7–dependent proliferation can be limited
during these developmental transitions to regulate the
number of mature cells emerging to the periphery. Here,
we present evidence that the IL-7–dependent proliferation
of pre-B cells is constrained by an inhibitory signal initiated
through antigen receptor assembly. 
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Materials and Methods
 
Cells.
 
IL-7–dependent cells derived from normal bone mar-
row (16) were maintained in growth medium with 10 ng/ml of
recombinant IL-7 (Genzyme Diagnostics). The retroviral packag-
ing cell lines CRE (17), AM12 GP 
 
1
 
 env (18), and 
 
F
 
nx (19)
were used, and were maintained in DMEM with 10% FCS.
 
Immunofluorescence Staining and Flow Cytometric Analysis.
 
Cells
were washed in ice-cold PBS. Staining for CD19 and CD43 was
with FITC-conjugated rat anti–mouse CD19 and with a biotiny-
lated rat anti–mouse CD43, followed by streptavidin-R-PE.
Staining for CD2 was with PE-conjugated rat anti–mouse CD2,
and for CD25, with an FITC-conjugated rat anti–mouse CD25.
All of these reagents were from PharMingen. Staining for 
 
m
 
 was
with FITC-conjugated goat anti–mouse 
 
m
 
 (
 
m
 
 chain specific;
Southern Biotechnology Associates), whereas staining for 
 
k
 
 light
chain was with PE-conjugated goat anti–mouse 
 
k
 
 (
 
k
 
 chain spe-
cific; Southern Biotechnology Associates). Staining for 
 
l
 
1 light
chain was with FITC-conjugated goat anti–mouse 
 
l
 
 (
 
l
 
 chain
specific; Southern Biotechnology Associates). Receptors for hu-
man IL-4R were detected with biotinylated human IL-4 (R&D
Systems), followed by streptavidin-PE (PharMingen). Staining for
the murine IL-7R was with rat anti–mouse IL-7R (A7R34; gift
of S. Nishikawa, Kyoto University, Kyoto, Japan), followed by a
biotinylated anti–rat antibody (PharMingen) and streptavidin-
FITC (Jackson ImmunoResearch Labs). Negative control stain-
ing was with the matched isotype controls (PharMingen). All
samples were analyzed on a FACScalibur™ flow cytometer (Bec-
ton Dickinson) by standard methods using CELLQuest™ analysis
software.
 
Sequencing of the Productive IgH Rearrangement.
 
A PCR-based
assay for V
 
H
 
 rearrangements was first carried out. High-molecu-
lar-weight genomic DNA was extracted by the Proteinase K
method, and subjected to two rounds of PCR. Nested 3
 
9
 
 primers
from the intron downstream of the J
 
H
 
4 and nested 5
 
9
 
 primers
corresponding to V
 
H
 
7183 and V
 
H
 
J558 V region families have al-
ready been described (20). Southern blotting of PCR products
using a V
 
H
 
7183 family–specific probe (20) confirmed that the re-
arrangement utilized a member of this family. The PCR product
was then gel purified and sequenced using a nested primer corre-
sponding to the 5
 
9
 
 end of V
 
H
 
7183 (20). Sequence comparisons
were carried out using the BLAST search algorithms (available at
http://www.ncbi.nlm.nih.gov/BLAST).
 
Pre-B Cell Cloning Assay.
 
The pre-B cell line was cloned by
limiting dilution in the presence of 10 ng/ml recombinant IL-7
(Genzyme Diagnostics). The pre-B cells were plated at 0.3 cells
per well in 96-well plates and then cultured in recombinant IL-7
containing medium for 2 wk. The colonies were then removed,
and 100 were analyzed for the expression of 
 
k
 
 light chain, as de-
scribed above.
 
Retroviral Constructs and Their Transfection into the Ecotropic Pack-
aging Cell Line.
 
The human (hu)IL-4R/IL-7R and the huIL-
4R/IL-2R
 
b
 
 are the same constructs that were used in Corcoran
et al. (8). The huIL-4R/IL-7R Tyr410Phe and the huIL-4R/IL-
7R Tyr456Phe were generated with a PCR-based strategy using
oligonucleotides encoding the desired point mutations. The
Tyr456Phe mutation is at the extreme 3
 
9
 
 end of the coding
sequence, and so the huIL-4R/IL-7RY456 mutant was con-
structed simply by PCR amplification using the wild-type huIL-
4R/IL-7R receptor (8) as a template (forward, 5
 
9
 
-AGCTGAA-
CGCGTCCATGGGGTGGCTTTGCTCTGGGCTC-3
 
9
 
;  reverse,
5
 
9
 
-AACTCTGAGTCTCACTGGTTTTGGAAGCTGGAC-3
 
9
 
).
For the Tyr410Phe mutation, the oligonucleotide encoding the
mutation (5
 
9
 
-CTAGACTGCAGGGAGAGTGGCAAGAATGGG-
 
CCTCAT-3
 
9
 
) and a reverse primer from the 3
 
9
 
 end of the coding
sequence (5
 
9
 
-AGCTTGTCTTCACTGGTTTTGGTAGAA-3
 
9
 
)
were used in PCR to generate a cytoplasmic domain fragment
encoding the desired alteration. After digestion with PstI and
BglII, the fragment was cloned into the corresponding sites in the
cytoplasmic domain of the huIL-4R/IL-7R wild-type receptor.
The huIL-4R/IL-7R Tyr410Phe and the huIL-4R/IL-7R
Tyr456Phe were then digested with MluI and BglII and ligated
into the MluI and BamHI sites of a vector based on the Moloney
leukemia provirus (8) rendered replication defective by deletion
of the 
 
pol
 
 and 
 
env 
 
genes.
The bicistronic expression vectors containing the rearranged 
 
l
 
1
light chain gene cDNA and the huIL-4R/IL-7R, huIL-4R/IL-
2R
 
b
 
, and huIL-4R/IL-7R Tyr410Phe chimeric receptors were also
constructed using a PCR-based approach. The 
 
l
 
1 light chain
cDNA was used as a template for two oligonucleotides (for-
ward, 5
 
9
 
-TCTACAACGCGTCCATGGCCTGGATTTCACTT-
ATA-3
 
9
 
; reverse, 5
 
9
 
-TCTAGAGGATCCGCGGCCGCTAGG-
AACAGTCAGCAC-3
 
9
 
), which contained MluI and BamHI sites,
respectively. The 
 
l
 
1 light chain fragment was linked through an
internal ribosome entry site (IRES) from the EMC virus to a
cDNA encoding the huIL-4R/IL-7R, huIL-4R/IL-2R
 
b
 
, or huIL-
4R/IL-7R Tyr410Phe chimeric receptors. A three-way ligation
was performed using: 
 
l
 
1 fragment digested MluI, BamHI; IRES
fragment digested BamHI, NcoI; and the chimeric receptor cDNAs
digested NcoI, NotI. These chimeric receptor sequences were
generated with the correct template using oligonucleotides con-
taining NcoI and NotI sites at the 5
 
9
 
 and 3
 
9
 
 ends of the fragment,
respectively. The three-way digestion products were then inserted
into the MluI and NotI sites of the retroviral vector. The integrity
of all constructs was confirmed by nucleotide sequencing.
Constructs were cotransfected by the calcium phosphate
method into an ecotropic packaging cell line (17) with a plasmid
encoding NeoR. Stable transfectants were isolated by selection in
1 mg/ml of G418 sulfate (GIBCO BRL).
 
Retrovirus-mediated Gene Transfer in Cultures of the Pre-B Cell
Line.
 
Pre-B cells were incubated at 10
 
6
 
 cells/ml, on a 20% con-
fluent monolayer of 2,000-rad 
 
g
 
-irradiated retrovirus-secreting
packaging cells, in RPMI 1640 medium containing 10% FCS,
5 
 
3
 
 10
 
2
 
5
 
 
 
b
 
-mercaptoethanol (growth medium), and 10 ng/ml
recombinant IL-7 (Genzyme Diagnostics) at 37
 
8
 
C in a 5% CO
 
2
 
atmosphere. After 2 d, cultures were washed and transferred to
growth medium containing 10 ng/ml IL-4 (Genzyme Diagnos-
tics) and 5 
 
3
 
 10
 
2
 
5
 
 
 
b
 
-mercaptoethanol (growth medium) and
then fed every 3–4 d by removal of spent medium and replace-
ment with new.
 
Proliferation Assays.
 
Cells (5 
 
3
 
 10
 
5
 
) were washed and resus-
pended in 3 ml of growth medium. The cells were then incu-
bated for 4 d at 37
 
8
 
C in 96-well microtiter plates in 100 
 
m
 
l of
growth medium containing the indicated quantities of recombi-
nant human IL-4 or recombinant mouse IL-7 (Genzyme Diag-
nostics). Proliferation was quantified using the MTT assay (21).
 
Results and Discussion
 
A Line of Pre-B I Cells from Normal Murine Bone Marrow
Divides Continuously in IL-7.
 
We used a line of pre-B
cells isolated from normal murine bone marrow (16) to
study the mechanisms that limit IL-7 responsiveness during
B lymphopoiesis. These cells express markers characteristic
of the pre-B I stage in development (Fig. 1 A). Thus, in ad- 
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dition to the CD19 marker typical of the B lineage (22),
the cells display the marker CD43, whose expression is lost
upon differentiation to the pre-B II stage (10). They also
express BP-1 (16), whose expression commences at Hardy
stage C (10). Finally, the cells fail to display CD25, a
marker that commences its expression at the pre-B II stage
of B cell development (23, 24).
This pre-B I cell line divides continuously in the pres-
ence of IL-7 (Fig. 1 B). We have found no alteration in IL-7
responsiveness after multiple rounds of passage over a pe-
riod of 3 yr (data not shown).
In these cells, a productive 
 
IgH
 
 gene rearrangement re-
sults in the synthesis of membrane-inserted 
 
m 
 
heavy chains
(Fig. 1 A). We have sequenced
 
 
 
this productive rearrange-
ment (Fig. 2 A). It involves a V
 
H
 
 gene segment from the
V
 
H
 
7183 family located in the D-proximal region of the
murine 
 
IgH
 
 locus. Comparison of the sequence with
known members of the family reveals a precise match with
V
 
H
 
7183.2 (Fig. 2 B; reference 25). In contrast, the 
 
IgL
 
genes remain in the germline configuration (16).
 
Differentiation to the 
 
m
 
1
 
, 
 
k
 
1
 
 Stage Results in the Loss of IL-7
Responsiveness.
 
A small fraction of cells in this pre-B I
cell line spontaneously undergoes differentiation to the
 
m
 
1
 
, 
 
k
 
1
 
 stage during propagation in culture (Fig. 1 A). Al-
though 
 
$
 
95% of the cells lack 
 
k
 
 expression, between 0.5
and 5% are consistently 
 
k
 
1
 
 at any given time. Interest-
ingly, the fraction of 
 
k
 
1
 
 cells fails to increase even after
prolonged periods in culture (data not shown), indicating
that they do not grow out in an IL-7–dependent manner.
This suggested to us that differentiation to the 
 
m
 
1
 
, 
 
k
 
1
 
stage might be accompanied by the loss of IL-7 respon-
siveness.
To confirm that this was indeed the case, the pre-B I
cells were cloned at limiting dilution in the presence of IL-
7, and the resulting clones were analyzed for expression of
a rearranged 
 
k
 
 chain gene. As shown in Table I, this pro-
cedure gave rise exclusively to cell clones that were 
 
$
 
95%
 
k
 
2
 
, just as are the parental cells. Thus, cells that have dif-
ferentiated to the 
 
m
 
1
 
, 
 
k
 
1
 
 stage cannot be cloned out in IL-
7, indicating that IL-7 responsiveness is indeed lost.
 
Loss of IL-7 Responsiveness Occurs Despite the Continuing
Expression of IL-7R.
 
We reasoned that the loss of IL-7
responsiveness upon differentiation might result from the
downregulation of IL-7R expression. To test this possibil-
ity, surface expression of the IL-7R was compared in 
 
k
 
1
 
and 
 
k
 
2 cells using an mAb specific to the a chain of the
mouse IL-7R. Fig. 3 A demonstrates that IL-7R expres-
sion is detected to a similar level in both the k1 and the k2
fractions. These results suggest that, contrary to expecta-
tion, the loss of IL-7 responsiveness in m1, k1 cells cannot
simply be ascribed to the lack of IL-7R expression.
Figure 1. (A) Shows that markers characteristic of
the pre-B I stage in differentiation are expressed by the
pre-B cell line used in these studies. The panels show
the results of flow cytometric analyses of 10,000 cells
after staining with antibodies against the indicated
markers. Forward and side light scatter profiles were
used to exclude dead cells. (B) Demonstrates the dose-
dependent proliferation of the pre-B cells in response
to IL-7. Proliferation quantified by the MTT assay is
plotted on the y-axis against cytokine dose on the
x-axis. The solid and dotted lines compare the prolif-
eration of a pre-B cell culture tested at an interval of
.1 yr, showing that IL-7–dependent proliferation is
not lost after prolonged passage in culture. Results are
typical of at least three independent experiments.
Figure 2. (A) The sequence of
the productive IgH rearrange-
ment from the pre-B cell line.
(B) The V region sequence,
shaded grey in A, is aligned with
the sequence of VH7183.2. The
D segment (shaded black) and
the J region (unshaded) are also
marked in A.
Table I. k1 Cells Responsive to IL-7 Cannot Be Cloned Out
Cell dilution
No. of clones
analyzed
No. of k2 clones
(#5% k1) No. of k1 clones
0.3 cells/well 100 100 0
Pre-B cells were cloned at limiting dilution (0.3 cells/well) in 96-well
plates using culture medium containing 10 ng/ml of recombinant IL-7.
Cell surface expression of m and k in individual clones was determined
by flow cytometry as described above.740 IL-7R Signaling Inhibited by Antigen Receptor Assembly
Retroviral Transfer of a Chimeric HuIL-4R/IL-7R Receptor
Fails to Rescue m1, k1 Cell Outgrowth. To subject the va-
lidity of these observations to further test, we introduced a
cDNA encoding a huIL-4R/IL-7R chimeric receptor into
the pre-B I cells by retroviral gene transfer. The chimeric
molecule (Fig. 3 B) contains the extracellular sequences of
the human IL-4R, conferring strict, species-specific re-
sponsiveness to human IL-4 (26). However, its transmem-
brane and cytoplasmic domains are derived from the IL-
7R. Expression of the chimeric receptor is promoted by
the long terminal repeat sequence of the Moloney murine
leukemia virus, active in a wide range of cell types (17).
Therefore, it is not subject to the same transcriptional con-
straints as is the endogenous IL-7R.
Transduced pre-B I cells were selected in human IL-4
for expression of the huIL-4R/IL-7R before analysis. As
shown in Fig. 3 B, the huIL-4R/IL-7R supports the pro-
liferation of the k2 pre-B I cell population. However, the
chimeric receptor does not rescue the outgrowth of m1, k1
cells, further substantiating that the loss of IL-7 responsive-
ness at this developmental stage is not simply due to the
lack of IL-7R expression. Rather, our results suggest that
differentiation to the m1, k1 stage is accompanied by the
inhibition of proliferative signaling through the IL-7R.
Inhibition of Proliferative Signaling at the m1, k1 Stage Is
Specific to the IL-7R Cytoplasmic Domain. Accordingly, we
tested if replacement of the IL-7R cytoplasmic domain
with sequences from the related IL-2R b chain (27) could
overcome this inhibition. Pre-B I cells transduced with a
huIL-4R/IL-2Rb chimeric receptor were selected in hu-
man IL-4 before analysis for k expression. As shown in Fig.
3 C, the huIL-4R/IL-2Rb supports the outgrowth not
only of k2 pre-B I cells but also of cells that have differen-
tiated to the m1, k1 stage. This is in marked contrast to the
huIL-4R/IL-7R (Fig. 3 B). Thus, the loss of proliferative
signaling at this developmental stage is specific to the IL-
7R cytoplasmic domain. Taken together with the results in
Table I, this finding confirms that the differentiation of
pre-B I cells to the m1, k1 stage triggers the inhibition of
proliferative signaling through the IL-7R, despite continu-
ing expression of the receptor.
Antigen Receptor Assembly Initiates the Inhibition of Prolifera-
tive Signaling through the IL-7R. Our results suggest that
the assembly of a functional antigen receptor initiates the
inhibition of proliferative signaling through the IL-7R. To
test this hypothesis directly, we created bicistronic gene
constructs in which a rearranged l1 light chain gene was
linked through an IRES to a cDNA encoding either the
huIL-4R/IL-7R or huIL-4R/IL-2Rb chimeric receptors
(Table II). These constructs were introduced into pre-B I
cells by retroviral transduction, and l1-expressing cells
were selected in human IL-4.
As shown in Table II, l1-expressing cells were readily
detected in cultures transduced with the l1–IRES–huIL-
4R/IL-2Rb construct. These l1 cells could be maintained
in IL-4–dependent culture for .1 mo without loss of l ex-
pression (data not shown). In contrast, l1 cells could not
be isolated from cultures transduced with the l1–IRES–
huIL-4R/IL-7R construct in multiple independent experi-
ments, suggesting that their outgrowth was not supported
by signaling through the huIL-4R/IL-7R. Taken together,
our results indicate that assembly of a m, l1 antigen recep-
tor results in the loss of responsiveness to proliferative sig-
naling through the huIL-4R/IL-7R, and that this inhibi-
tion is specific to the cytoplasmic sequences of the IL-7R
but not the IL-2Rb.
Inhibition of Proliferative Signaling Is Dependent on Tyr410. To
Figure 3. (A) Shows that k1 and k2 pre-B cells stain with equal fre-
quency and intensity for the murine IL-7 (MIL7) receptor. (B and C) The
results of experiments with pre-B cells transduced with retrovirally en-
coded huIL-4R/IL-7R wild-type (WT) or huIL-4R/IL-2Rb chimeric
receptors. The top panel in each case shows that expression of the trans-
duced receptors is equivalent, whereas the bottom panels demonstrate the
marked difference in the capacity of the two chimeric receptors to sup-
port the outgrowth of k1 cells. Results are typical of at least three inde-
pendent experiments.
Table II. Ability of Chimeric Receptors to Support the Outgrowth 
of Cells Expressing a m, l1 Antigen Receptor
Construct n
Outgrowth of
m1, l1 cells
l1–IRES–huIL-4R/IL-7R 5 2
l1–IRES–huIL-4R/IL-2Rb 3 1
l1–IRES–huIL-4R/IL-7RY410F 3 1
Pre-B cells were transduced with bicistronic retroviruses encoding a l1
light chain cDNA linked through an IRES to chimeric cytokine receptors.
Transduced cells were selected in human IL-4 (10 ng/ml) for 7 d, and the
surface expression of m and l was determined by flow cytometry (see
Materials and Methods). n, the number of independent experiments.741 Smart and Venkitaraman Brief Definitive Report
investigate the mechanism by which this inhibitory signal
might act, we constructed a series of mutant huIL-4R/IL-
7R constructs in which cytosolic Tyr residues were altered
to Phe. The cytoplasmic domain of the IL-7R contains
three Tyr residues (Tyr410, Tyr449, and Tyr456) con-
served in evolution between the murine and human recep-
tors, suggesting an important function. The Tyr410Phe and
Tyr456Phe mutants were tested in these experiments be-
cause we have already shown that Tyr449, which recruits
the effector enzyme PI 3-k, is essential for proliferative sig-
naling through the IL-7R (8, 9).
Fig. 4 A shows that both the huIL-4R/IL-7R Tyr
410Phe and huIL-4R/IL-7R Tyr456Phe mutants are equally
proficient at supporting the proliferation of pre-B I cells.
Thus, neither residue is essential for proliferative signaling.
However, in contrast to both the wild-type receptor (Fig. 3
B) and the Tyr456Phe mutant (Fig. 4 C), the huIL-4R/
IL-7R Tyr410Phe mutant alone could support the out-
growth of m1, k1 cells (Fig. 4 B). This implies that muta-
tion of a single Tyr residue can overcome the inhibition of
proliferative signaling through the IL-7R.
Accordingly, we performed a further experiment in
which a rearranged l1 light chain gene was linked in a
bicistronic expression vector to the huIL-4R/IL-7R Tyr
410Phe mutant receptor (Table II). In contrast to the huIL-
4R/IL-7R, but like the huIL-4R/IL-2Rb, the Tyr410Phe
mutant was competent to support the outgrowth of l1-
expressing cells. Taken together, these results confirm that the
inhibitory signal initiated by antigen receptor assembly is
critically dependent on the integrity of Tyr410 in the cyto-
plasmic domain of the IL-7R a chain. Therefore, we pro-
pose that the inhibitory signal may work through the re-
cruitment of an inhibitory molecule to this residue.
In summary then, the results we have presented in this
paper identify a novel mechanism that limits the expansion
of pre-B lymphocytes in the murine bone marrow. By sup-
pressing proliferative signaling through the IL-7R cytoplas-
mic domain upon antigen receptor assembly, this mecha-
nism provides a feedback loop that may regulate the
throughput of cells reaching the mature B lymphocyte
stage. The assembly of a functional pre-B cell receptor may
itself conceivably be sufficient to trigger this growth inhibi-
tory process (28, 29), restricting the number of divisions
pre-B cells can undergo before commencing IgL rearrange-
ment. Our findings demonstrate for the first time a homeo-
static mechanism that limits cytokine-dependent cell ex-
pansion during hematopoiesis.
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